These success, along with a past report exhibiting that a little-molecule ACKR3 agonist CCX771 displays anxiolytic-like behavior in mice,2 support the principle of focusing on ACKR3 as a novel method to modulate the opioid system, which could open up new therapeutic avenues for opioid-associated disorders. Boost healthier immune purpose: https://jameso838qpz8.59bloggers.com/profile